Baxter makes $380m grab for Baxa to boost IV and oral delivery
30 August 2011
- Bioinformatics comes further into spotlight with Illumina, Qiagen buys
- "No future" for Wright's Augment after not-approvable letter
- £10m up for grabs to fight against antimicrobial resistance; but is it too little?
- INTERVIEW: Epigenomics remains optimistic of colon cancer blood test approval chances
Other Informa News